[{"address1": "Tower 11", "address2": "Level 10, Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "59200", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2445, "open": 0.2289, "dayLow": 0.2251, "dayHigh": 0.2636, "regularMarketPreviousClose": 0.2445, "regularMarketOpen": 0.2289, "regularMarketDayLow": 0.2251, "regularMarketDayHigh": 0.2636, "payoutRatio": 0.0, "beta": 0.155, "forwardPE": -0.12623115, "volume": 1642609, "regularMarketVolume": 1642609, "averageVolume": 2411475, "averageVolume10days": 13399170, "averageDailyVolume10Day": 13399170, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 52082800, "fiftyTwoWeekLow": 0.17, "fiftyTwoWeekHigh": 3.08, "priceToSalesTrailing12Months": 1211.2279, "fiftyDayAverage": 0.2796, "twoHundredDayAverage": 0.6547, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 48945900, "profitMargins": 0.0, "floatShares": 12707647, "sharesOutstanding": 207336000, "sharesShort": 27619, "sharesShortPriorMonth": 53583, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0001, "heldPercentInsiders": 0.51085997, "heldPercentInstitutions": 0.00191, "shortRatio": 0.16, "shortPercentOfFloat": 0.0022, "impliedSharesOutstanding": 207336000, "bookValue": -0.245, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -11212000, "trailingEps": -2.09, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1702857600, "enterpriseToRevenue": 1138.277, "enterpriseToEbitda": -4.08, "52WeekChange": -0.87922704, "SandP52WeekChange": 0.09765589, "lastDividendValue": 0.15, "lastDividendDate": 1745884800, "quoteType": "EQUITY", "currentPrice": 0.2512, "recommendationKey": "none", "totalCash": 3137000, "totalCashPerShare": 0.015, "ebitda": -11998000, "totalDebt": 0, "quickRatio": 0.5, "currentRatio": 0.586, "totalRevenue": 43000, "revenuePerShare": 0.008, "returnOnAssets": -1.16327, "grossProfits": 43000, "freeCashflow": -5268500, "operatingCashflow": -7990000, "revenueGrowth": -1.0, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -279.16278, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1746229917, "regularMarketTime": 1746216001, "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "earningsTimestamp": 1743624300, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.09, "epsForward": -1.99, "fiftyDayAverageChange": -0.028400004, "fiftyDayAverageChangePercent": -0.10157369, "twoHundredDayAverageChange": -0.4035, "twoHundredDayAverageChangePercent": -0.6163128, "priceToBook": -1.0253061, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": 2.740284, "regularMarketPrice": 0.2512, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "postMarketChangePercent": 0.636942, "postMarketPrice": 0.2528, "postMarketChange": 0.0016, "regularMarketChange": 0.006699994, "regularMarketDayRange": "0.2251 - 0.2636", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2411475, "fiftyTwoWeekLowChange": 0.08119999, "fiftyTwoWeekLowChangePercent": 0.47764698, "fiftyTwoWeekRange": "0.17 - 3.08", "fiftyTwoWeekHighChange": -2.8288, "fiftyTwoWeekHighChangePercent": -0.9184416, "fiftyTwoWeekChangePercent": -87.92271, "dividendDate": 1746057600, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]